{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:10:19Z","timestamp":1784567419678,"version":"3.55.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Cutaneous sarcoidosis can manifest after doing a permanent makeup (PMU), such as tattooed eyebrows. A 41-year-old Chinese woman, with a tattoo in the eyebrows, developed yellow\u2013brown plaques in her eyebrows for several months. A dermatopathological examination revealed non-caseating granulomas consistent with cutaneous sarcoidosis. For months, topical corticosteroids were applied, which showed little effect. Furthermore, a physical evaluation of the patient revealed no apparent involvement of other body organs except bilateral hilar lymphadenopathy with few diffuse reticulonodular opacities. On the basis of fully informed consent, the patient agreed to a 6-month initial follow-up to avoid unnecessary PMU.<\/jats:p>","DOI":"10.3389\/fmed.2022.1009135","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T04:48:28Z","timestamp":1668746908000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Eyebrow tattoo-associated sarcoidosis: A case report"],"prefix":"10.3389","volume":"9","author":[{"given":"Shu","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zile","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","article-title":"Statement on sarcoidosis. Joint statement of the American thoracic society (ATS), the European respiratory society (ERS) and the world association of sarcoidosis and other granulomatous disorders (WASOG) adopted by the ATS board of directors and by the ERS executive committee, February 1999.","volume":"160","author":"Hunninghake","year":"1999","journal-title":"Am J Respair Crit Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijd.12566","article-title":"Cutaneous sarcoidosis: an intriguing model of immune dysregulation.","volume":"54","author":"Ruocco","year":"2015","journal-title":"Int J Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.amjmed.2020.04.027","article-title":"Tattoo-associated sarcoidosis.","volume":"133","author":"Hirani","year":"2020","journal-title":"Am J Med."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66620-2","article-title":"Sarcoidosis in a gecko.","volume":"365","author":"McGavin","year":"2005","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000468536","article-title":"Cutaneous complications related to tattoos: 31 cases from Finland.","volume":"233","author":"Kluger","year":"2017","journal-title":"Dermatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management.","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000369175","article-title":"Epidemiology of tattoos in industrialized countries.","volume":"48","author":"Kluger","year":"2015","journal-title":"Curr Probl Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1111\/jdv.16115","article-title":"Tattoos and self-reported adverse events in sarcoidosis patients.","volume":"34","author":"van der Bent","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis.","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells."},{"key":"B10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/MCP.0000000000000077","article-title":"Clinical phenotypes in sarcoidosis.","volume":"20","author":"Pereira","year":"2014","journal-title":"Curr Opin Pulm Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/2040622318790197","article-title":"Epidemiology of sarcoidosis: current findings and future directions.","volume":"9","author":"Arkema","year":"2018","journal-title":"Ther Adv Chronic Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis.","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest."},{"key":"B13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2018.11.010","article-title":"Sarcoidosis deaths in the United States: 1999-2016.","volume":"149","author":"Kearney","year":"2019","journal-title":"Respir Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/archderm.133.7.882","article-title":"Cutaneous involvement in sarcoidosis. relationship to systemic disease.","volume":"133","author":"Ma\u00f1\u00e1","year":"1997","journal-title":"Arch Dermatol."},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis.","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1111\/jocd.14498","article-title":"Complications of tattoos and permanent makeup: overview and analysis of 308 cases.","volume":"20","author":"van der Bent","year":"2021","journal-title":"J Cosmet Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00204-020-02655-z","article-title":"Safety of tattoos and permanent make-up: a regulatory view.","volume":"94","author":"Giulbudagian","year":"2020","journal-title":"Arch Toxicol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1009135\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T04:48:30Z","timestamp":1668746910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1009135\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":17,"alternative-id":["10.3389\/fmed.2022.1009135"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1009135","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"article-number":"1009135"}}